Mangoceuticals, Common Stock Stock Market Value
| MGRX Stock | 2.37 0.14 5.58% |
| Symbol | Mangoceuticals, |
Mangoceuticals, Common Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mangoceuticals, Common. If investors know Mangoceuticals, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mangoceuticals, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.45) | Revenue Per Share 0.615 | Quarterly Revenue Growth 0.155 | Return On Assets (0.58) | Return On Equity (1.08) |
The market value of Mangoceuticals, Common is measured differently than its book value, which is the value of Mangoceuticals, that is recorded on the company's balance sheet. Investors also form their own opinion of Mangoceuticals, Common's value that differs from its market value or its book value, called intrinsic value, which is Mangoceuticals, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mangoceuticals, Common's market value can be influenced by many factors that don't directly affect Mangoceuticals, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mangoceuticals, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mangoceuticals, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mangoceuticals, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mangoceuticals, Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mangoceuticals, Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mangoceuticals, Common.
| 09/24/2024 |
| 10/24/2024 |
If you would invest 0.00 in Mangoceuticals, Common on September 24, 2024 and sell it all today you would earn a total of 0.00 from holding Mangoceuticals, Common Stock or generate 0.0% return on investment in Mangoceuticals, Common over 30 days. Mangoceuticals, Common is related to or competes with FOXO Technologies, Healthcare Triangle, Bullfrog, and EUDA Health. Mangoceuticals, Common is entity of United States More
Mangoceuticals, Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mangoceuticals, Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mangoceuticals, Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 37.65 | |||
| Value At Risk | (10.68) | |||
| Potential Upside | 9.65 |
Mangoceuticals, Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mangoceuticals, Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mangoceuticals, Common's standard deviation. In reality, there are many statistical measures that can use Mangoceuticals, Common historical prices to predict the future Mangoceuticals, Common's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.32) | |||
| Total Risk Alpha | (1.86) | |||
| Treynor Ratio | (2.14) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mangoceuticals, Common's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mangoceuticals, Common Backtested Returns
Mangoceuticals, Common has Sharpe Ratio of -0.21, which conveys that the firm had a -0.21% return per unit of risk over the last 3 months. Mangoceuticals, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mangoceuticals, Common's Mean Deviation of 4.56, standard deviation of 6.47, and Risk Adjusted Performance of (0.15) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.6, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mangoceuticals, Common's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mangoceuticals, Common is expected to be smaller as well. At this point, Mangoceuticals, Common has a negative expected return of -1.37%. Please make sure to verify Mangoceuticals, Common's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Mangoceuticals, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.04 |
Very weak reverse predictability
Mangoceuticals, Common Stock has very weak reverse predictability. Overlapping area represents the amount of predictability between Mangoceuticals, Common time series from 24th of September 2024 to 9th of October 2024 and 9th of October 2024 to 24th of October 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mangoceuticals, Common price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Mangoceuticals, Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Mangoceuticals, Common lagged returns against current returns
Autocorrelation, which is Mangoceuticals, Common stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mangoceuticals, Common's stock expected returns. We can calculate the autocorrelation of Mangoceuticals, Common returns to help us make a trade decision. For example, suppose you find that Mangoceuticals, Common has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mangoceuticals, Common regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mangoceuticals, Common stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mangoceuticals, Common stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mangoceuticals, Common stock over time.
Current vs Lagged Prices |
| Timeline |
Mangoceuticals, Common Lagged Returns
When evaluating Mangoceuticals, Common's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mangoceuticals, Common stock have on its future price. Mangoceuticals, Common autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mangoceuticals, Common autocorrelation shows the relationship between Mangoceuticals, Common stock current value and its past values and can show if there is a momentum factor associated with investing in Mangoceuticals, Common Stock.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.